This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Biologics in Otolaryngology: Past, Present, and Future - p. 675 10. Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis - p. 689 11. Choosing the Right Patient for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis: Endotypes, Patient Characteristics, and Defining Failures of Standard Therapy - p. 701 12. Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice - p. 709 13. Mechanisms and Practical Use of Biologic Therapies for Allergy and Asthma Indications - p. 717 14. Immunotherapeutic Strategies for Head and Neck Cancer - p. 729 15. Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer - p. 743 16. Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance - p. 751 17. Advances in Adoptive Cell Therapy for Head and Neck Cancer - p. 761 18. Biologics for the Treatment of Recurrent Respiratory Papillomatosis - p. 769 19. Past and Future Biologics for Otologic Disorders - p. 779 20. Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders - p. 789 21. Biologics for Immune-Mediated Sensorineural Hearing Loss - p. 803 22. Special Article Series: Intentionally Shaping the Future of Otolaryngology - p. 803 23. Foreword - p. xvii 24. Preface - p. xxi 25. Women in Academic Medicine and Leadership - p. 815 26. Balance Versus Integration: Work-Life Considerations - p. 823
This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Biologics in Otolaryngology: Past, Present, and Future - p. 675 10. Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis - p. 689 11. Choosing the Right Patient for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis: Endotypes, Patient Characteristics, and Defining Failures of Standard Therapy - p. 701 12. Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice - p. 709 13. Mechanisms and Practical Use of Biologic Therapies for Allergy and Asthma Indications - p. 717 14. Immunotherapeutic Strategies for Head and Neck Cancer - p. 729 15. Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer - p. 743 16. Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance - p. 751 17. Advances in Adoptive Cell Therapy for Head and Neck Cancer - p. 761 18. Biologics for the Treatment of Recurrent Respiratory Papillomatosis - p. 769 19. Past and Future Biologics for Otologic Disorders - p. 779 20. Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders - p. 789 21. Biologics for Immune-Mediated Sensorineural Hearing Loss - p. 803 22. Special Article Series: Intentionally Shaping the Future of Otolaryngology - p. 803 23. Foreword - p. xvii 24. Preface - p. xxi 25. Women in Academic Medicine and Leadership - p. 815 26. Balance Versus Integration: Work-Life Considerations - p. 823
